Form 4: Semler Scientific CEO Douglas Murphy-Chutorian Sells Shares
SEC Form 4 Filing
Semler Scientific's CEO, Douglas Murphy-Chutorian, recently sold shares of the company's common stock in multiple transactions.
Summary
- Douglas Murphy-Chutorian, CEO of Semler Scientific, sold 780 shares of common stock on August 28, 2024, at a weighted average price of $28.3164.
- He then sold 10,000 shares on August 29, 2024, at a weighted average price of $28.3453.
- Following these transactions, Murphy-Chutorian directly owns 60,220 shares and indirectly owns 23,571 shares through a family trust.
- The shares held in the family trust are managed jointly with his spouse, with shared voting and investment power.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions without expressing any opinion on the company's performance or future prospects.
Industry Context
Insider sales are a common occurrence and are often scrutinized by investors for insights into management's perspective on the company's valuation and future prospects. However, they don't always indicate a negative outlook, as executives may sell shares for various personal financial reasons.
Stakeholder Impact
- Shareholders may react to the news of the CEO selling shares, potentially impacting the stock price.
Key Dates
| Date | Description |
|---|---|
| 08/28/2024 | Sale of 780 shares of common stock at a weighted average price of $28.3164. |
| 08/29/2024 | Sale of 10,000 shares of common stock at a weighted average price of $28.3453. |
| 08/30/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.